Cargando…
Multi gene panel testing for hereditary breast cancer - is it ready to be used?
Breast cancer is one of the most common malignancies and the leading cause of death among women worldwide. About 20% of breast cancers are hereditary. Approximately 30% of the mutations have remained negative after testing BRCA1/2 even in families with a Mendelian inheritance pattern for breast canc...
Autores principales: | Catana, Andreea, Apostu, Adina Patricia, Antemie, Razvan-Geo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709965/ https://www.ncbi.nlm.nih.gov/pubmed/31460501 http://dx.doi.org/10.15386/mpr-1083 |
Ejemplares similares
-
The determination factors of left-right asymmetry disorders- a short review
por: CATANA, ANDREEA, et al.
Publicado: (2017) -
Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis
por: Anaclerio, Federico, et al.
Publicado: (2023) -
Blue Light—Ocular and Systemic Damaging Effects: A Narrative Review
por: Antemie, Răzvan-Geo, et al.
Publicado: (2023) -
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients
por: Crawford, Beth, et al.
Publicado: (2017) -
Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)